Azithromycin treatment of gingival hyperplasia in kidney transplant recipients is effective and safe

Transplant Proc. 2001 May;33(3):2134-5. doi: 10.1016/s0041-1345(01)01973-x.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use
  • Area Under Curve
  • Azithromycin / adverse effects
  • Azithromycin / therapeutic use*
  • Creatinine / blood
  • Cyclosporine / blood
  • Cyclosporine / pharmacokinetics
  • Cyclosporine / therapeutic use
  • Follow-Up Studies
  • Gingival Hyperplasia / drug therapy*
  • Humans
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / pharmacokinetics
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation* / physiology
  • Postoperative Complications*
  • Recurrence
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Immunosuppressive Agents
  • Azithromycin
  • Cyclosporine
  • Creatinine